Summary

Overview
The global Alternative Cancer Treatment market reached US$ XX million in 2024 and is expected to reach US$ XX million by 2033, growing at a CAGR of XX% during the forecast period 2025-2033.
Alternative cancer treatment encompasses a variety of therapies and practices that are not part of conventional cancer care. These treatments are often sought by patients looking for complementary options to traditional therapies or those seeking to manage symptoms and improve quality of life.
The alternative cancer treatment market is diverse, reflecting a wide range of approaches from herbal remedies to holistic practices. Alternative cancer treatment includes a variety of approaches such as Ayurveda, homeopathy, naturopathy and traditional Chinese medicine.
Market Dynamics: Drivers & Restraints
Rising prevalence of cancer cases
The rising burden of cancer is expected to significantly drive the alternative cancer treatment market as more patients seek complementary therapies to manage their conditions. For instance, according to the National Institute of Health in 2024, it is stated that By 2050, the total number of cancer cases is projected to increase to 35.3 million, an increase of 76.6% from the 2022 estimate of 20 million. With this rise, there is an urgent need for effective treatment options beyond conventional therapies.
As cancer incidence continues to grow, patients are increasingly exploring alternative treatments such as dietary supplements, acupuncture, and herbal remedies to alleviate symptoms and improve quality of life. This shift is fueled by a desire for holistic care approaches that address not only the disease but also the emotional and physical well-being of patients. Additionally, the limitations of conventional treatments—such as side effects and high costs—prompt patients to consider alternative options as viable adjuncts to their primary care.
Competition from Existing Treatments
Competition from conventional treatments is expected to significantly hinder the alternative cancer therapeutics market for several reasons. Conventional cancer therapies, including chemotherapy, radiation therapy, and immunotherapy, are backed by extensive scientific research and clinical trials that validate their efficacy and safety. These established treatments have proven their efficiency in combating cancer and improving patient outcomes, which can overshadow alternative therapies that often lack rigorous clinical evidence.
Segment Analysis
The global alternative cancer treatment market is segmented based on therapy type, indication, and region.
Treatment:
Hormone Therapy segment is expected to dominate the global alternative cancer treatment market share
Hormone therapies are expected to dominate the alternative cancer therapeutics market due to their established efficacy in treating hormone-sensitive cancers, particularly breast and prostate cancer. These therapies work by blocking hormones that fuel the growth of certain tumors, effectively slowing or stopping cancer progression.
With a significant percentage of breast cancers classified as estrogen receptor-positive, hormone therapy is often employed as a primary treatment option, either alone or in conjunction with surgery and chemotherapy. The increasing recognition of the role hormones play in cancer biology has led to a growing acceptance of hormone therapies among both patients and healthcare providers.
Additionally, ongoing research continues to enhance the understanding of hormonal mechanisms in cancer, leading to the development of new and more effective hormone-based treatments. As a result, hormone therapies are positioned in a dominant role in the alternative cancer therapeutics market.
Geographical Analysis
North America is expected to hold a significant position in the global alternative cancer treatment market share
North America is expected to hold a significant position in the global alternative cancer treatment market due to several key factors. The region benefits from a high level of patient awareness regarding various cancer treatments, including alternative and complementary therapies, which fosters a more informed consumer base. Additionally, the presence of numerous market players and healthcare institutions that actively promote and research alternative therapies contributes to the region's dominance.
The increasing prevalence of cancer, coupled with a growing preference for holistic and personalized medicine approaches, drives demand for alternative treatments. Individuals are seeking lesser dosages and drugs with fewer side effects. A large number of individuals are shifting towards alternative medicines. For instance, according to a study published by the National Institute of Health in 2024, 51.83% of the participants reported using complementary and alternative medicine (CAM), with usage ranging from 6.4% to 100%. As a result, North America is poised to maintain a leading share in the alternative cancer treatment market.
Competitive Landscape
The major global players in the alternative cancer treatment market iHerb, LLC., Pyrexar Medical, AYURSUN PHARMA, Pristine Organics Pvt Ltd., Polycare Herbals, ZENES BIOTECH PRIVATE LIMITED, Rajasthan Aushdhalaya Pvt. Ltd., and Wilson Drug among others.
Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The Global Alternative Cancer Treatment Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.

• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.

• Supply Chain: Distribution and Supply Chain Managers.

• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

• Academic & Research: Academic Institutions.

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Therapy Type
3.2. Snippet by Indication
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of benign prostatic hyperplasia
4.1.2. Restraints
4.1.2.1. Adverse Effects of Treatments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs
6. By Therapy Type
6.1. Introduction
6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
6.1.2. Market Attractiveness Index, By Therapy Type
6.2. Hormone Therapies*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Acupuncture
6.4. Hyperthermia
6.5. Dietary Supplements
6.6. Ayurveda
6.7. Others
7. By Indication
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.1.2. Market Attractiveness Index, By Indication
7.2. Gastrointestinal Cancer*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Lung Cancer
7.4. Breast Cancer
7.5. Colorectal Cancer
7.6. Prostate Cancer
7.7. Leukemia
7.8. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Spain
8.3.5.5. Italy
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. South Korea
8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
Key Market Players
10.1. iHerb, LLC.*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue’s
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals etc.
10.1.5. SWOT Analysis
10.2. Pyrexar Medical
10.3. AYURSUN PHARMA
10.4. Pristine Organics Pvt Ltd.
10.5. Polycare Herbals
10.6. ZENES BIOTECH PRIVATE LIMITED
10.7. Rajasthan Aushdhalaya Pvt. Ltd.
10.8. Wilson Drug
* Similar data will be provided for each market player.
LIST NOT EXHAUSTIVE
11. Appendix
11.1. About Us and Services
11.2. Contact Us